NasdaqCM - Delayed Quote USD
SAB Biotherapeutics, Inc. (SABS)
Tune into live earnings calls Now streaming directly on quote pages.
1.7100
-0.1210
(-6.61%)
At close: June 13 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ELLIAS HELEN K Director | Conversion of Exercise of derivative security | Nov 24, 2023 | -- |
| KING MICHAEL Chief Financial Officer | Purchase | Nov 30, 2023 | 5,000 |
| MOIN ANDREW D. Director | Conversion of Exercise of derivative security | Nov 24, 2023 | -- |
| REICH SAMUEL J. Officer and Director | Purchase | Nov 29, 2023 | 766,699 |
| SESSA CAPITAL MASTER, L.P. Director | Conversion of Exercise of derivative security | Nov 24, 2023 | -- |
| SULLIVAN EDDIE JOE Chief Executive Officer | Purchase | Dec 7, 2023 | 5,232,300 |
Related Tickers
ANEB Anebulo Pharmaceuticals, Inc.
1.3900
+9.45%
SLXNW Silexion Therapeutics Corp
0.0633
-0.47%
CLCS Cell Source, Inc.
0.2978
+6.34%
NVV1.F Novavax, Inc.
6.06
-2.93%
ENSCW Leisure Acquisition Corp.
0.0241
+20.50%
SLRX Salarius Pharmaceuticals, Inc.
0.6573
-7.03%
PRTC PureTech Health plc
19.61
0.00%
CMMB Chemomab Therapeutics Ltd.
1.2000
-1.64%
SLXN Silexion Therapeutics Corp
0.8746
-1.24%
ACXP Acurx Pharmaceuticals, Inc.
0.3050
-7.60%